Abstract
This study assesses the clinical performance of the Souter-Strathclyde elbow arthroplasty with a standardised index and long term survivorship analysis.
We undertook assessment of 68 primary Souter-Strathclyde total elbow replacements. Of 53 patients assessed with pre-operative Souter-Strathclyde charts, nine died and one was lost to follow-up, 43 had radiographic and telephone review, and 38 (88%) had clinical examination according to the Mayo Elbow Performance Index.
Survival of the 43 elbows was to a mean of 72 months (range: eight to 187 months) with improvement in pain, motion, stability and function. Eight of 10 elbows in deceased patients had satisfactory scores at the last assessment. Ulnar neuropraxia occurred in eight elbows (12%), persistent sensory deficit in two (3%) and motor deficit in one. Two triceps abscesses required local skin flap cover. Revision was undertaken in 14 elbows (20%) for instability (six) bony injury (three), loosening (three) and intraoperative problems (two).
The survivorship at 13 years was 74% with 62 (91%) of all elbows achieving a satisfactory Mayo score.
The abstracts were prepared by Mr Roger Emery. Correspondence should be addressed to him at the British Orthopaedic Association, Royal College of Surgeons, 35-43 Lincoln’s Inn Fields, London WC2A 3PN
